1. Home
  2. LAW vs ESPR Comparison

LAW vs ESPR Comparison

Compare LAW & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

HOLD

Current Price

$8.36

Market Cap

466.2M

Sector

Technology

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.92

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAW
ESPR
Founded
2013
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
466.2M
898.5M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
LAW
ESPR
Price
$8.36
$3.92
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$7.75
$6.67
AVG Volume (30 Days)
295.7K
6.5M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$152,677,000.00
$303,802,000.00
Revenue This Year
$8.51
$25.45
Revenue Next Year
$7.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.33
2.83
52 Week Low
$3.31
$0.69
52 Week High
$9.11
$4.13

Technical Indicators

Market Signals
Indicator
LAW
ESPR
Relative Strength Index (RSI) 63.35 60.61
Support Level $8.20 $3.63
Resistance Level $8.72 $4.13
Average True Range (ATR) 0.37 0.21
MACD 0.01 -0.03
Stochastic Oscillator 64.45 60.19

Price Performance

Historical Comparison
LAW
ESPR

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: